Which condition is NOT associated with an increased Partial Thromboplastin Time (PITT)?

Which condition is NOT associated with an increased Partial Thromboplastin Time (PITT)?

• A. Hemophilia A
• B. Von Willebrand disease
• C. Liver disease
• D. Arterial thrombus

Answer: (D)

An increased Partial Thromboplastin Time (PTT) is typically observed in conditions where there is a disruption in the intrinsic pathway of coagulation or a deficiency in the factors involved in this pathway. Hemophilia A, Von Willebrand disease, and liver disease are all associated with such disruptions. Hemophilia A is a genetic disorder characterized by a deficiency in clotting factor VIII, which leads to prolonged PTT due to impaired ability to form a stable fibrin clot. Likewise, Von Willebrand disease impacts factor VIII function as well as platelet adhesion, resulting in an increased PTT. Liver disease affects the synthesis of multiple clotting factors responsible for hemostasis, which can lead to prolonged PTT and represents a broader issue in coagulation and liver function. In contrast, the presence of an arterial thrombus does not lead to an increased PTT. Instead, arterial thrombosis is more commonly associated with the activation of the extrinsic pathway and often relates to tissue factor exposure. This scenario typically does not affect the intrinsic pathway, and as a result, the PTT remains normal or unaffected. Thus, the condition that is not associated with an increased PTT is the presence of an arterial thrombus.

An increased Partial Thromboplastin Time (PTT) is typically observed in conditions where there is a disruption in the intrinsic pathway of coagulation or a deficiency in the factors involved in this pathway. Hemophilia A, Von Willebrand disease, and liver disease are all associated with such disruptions.

Hemophilia A is a genetic disorder characterized by a deficiency in clotting factor VIII, which leads to prolonged PTT due to impaired ability to form a stable fibrin clot. Likewise, Von Willebrand disease impacts factor VIII function as well as platelet adhesion, resulting in an increased PTT.

Liver disease affects the synthesis of multiple clotting factors responsible for hemostasis, which can lead to prolonged PTT and represents a broader issue in coagulation and liver function.

In contrast, the presence of an arterial thrombus does not lead to an increased PTT. Instead, arterial thrombosis is more commonly associated with the activation of the extrinsic pathway and often relates to tissue factor exposure. This scenario typically does not affect the intrinsic pathway, and as a result, the PTT remains normal or unaffected. Thus, the condition that is not associated with an increased PTT is the presence of an arterial thrombus.